Welsis (WLSS) Convertible Debt (2024 - 2025)
Welsis (WLSS) recorded quarterly Convertible Debt of $78417.0 in Q4 2025, up 15.5% quarter-over-quarter from $67892.0 in Q3 2025, and up 187.94% on a YoY basis from $27234.0 in Q4 2024.
Welsis (WLSS) Convertible Debt (2024 - 2025) Analysis & Trends
Welsis' Convertible Debt history runs 2 years deep, the most recent figure standing at $78417.0 for Q4 2025.
- In Q4 2025, Convertible Debt rose 187.94% year-over-year to $78417.0; the TTM figure through Dec 2025 stood at $78417.0 (up 187.94% YoY), while the FY2025 annual figure was $67892.0, up 278.33% from the prior year.
- Convertible Debt was $78417.0 for Q4 2025 at Welsis, up from $67892.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $78417.0 in Q4 2025 to a low of $10819.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Welsis | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78,417.00 |
| Sep 30, 2025 | 67,892.00 |
| Jun 30, 2025 | 64,998.00 |
| Mar 31, 2025 | 53,103.00 |
| Dec 31, 2024 | 27,234.00 |
| Sep 30, 2024 | 17,945.00 |
| Jun 30, 2024 | 10,819.00 |